MYC and hepatocellular carcinoma: MiR-122 directly inhibits the transcription factor C/EBPα and its own expression, by indirectly up-regulating the expression of the inhibitory transcription factor C/EBPα and c-myc. Inhibition of miR-122 expression during chronic hepatitis B (CHB) development in HCC promotes tumorigenesis (39).